Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,750,512
+$9,077,850 QoQ
Shares Held
219,596
-16.9% QoQ
Ownership
0.419%
of shares outstanding
% of Portfolio
4.67%
of 13F equity value
Holder Rank
#47
of 503 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Jun 30, 2023CallValue
$14,372,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. AXSM ranks #2 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
233,171 | $62,191,369 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
This page
|
219,596 | $53,750,512 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,768 | $38,740,264 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
308,385 | $29,219,478 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
143,222 | $26,822,616 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
253,358 | $18,870,103 | |
| 7 | CYTK |
Cytokinetics Inc
|
191,686 | $16,329,730 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,313 | $15,739,615 |
All Filings in AXSM
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,750,512 | 219,596 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $44,672,662 | 264,304 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $45,945,283 | 251,562 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $64,408,821 | 530,332 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $50,431,330 | 483,105 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $64,909,843 | 556,545 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $39,548,998 | 467,427 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $42,007,664 | 467,427 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $37,627,873 | 467,427 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $37,300,674 | 467,427 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $37,202,514 | 467,427 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $36,567,146 | 523,210 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $35,612,522 | 495,582 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $14,372,000 | 200,000 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $37,383,076 | 606,081 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $84,290,055 | 1,092,831 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $23,061,870 | 299,000 | Call | Defined | 2023-02-14 | |
| 2022-09-30 | $74,057,286 | 1,659,733 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,110,826 | 1,360,596 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||